Get the real deal on beauty treatments—real doctors, real reviews, and real photos with real results.Here's how we earn your trust.
As you have stated Latisse is intended for glaucoma management and it is unlikely to cause glaucoma if used in accordance with the package instructions. It may rarely cause discoloration of the skin or iris and also may cause unwanted hair growth if applied elsewhere.
There should be no concern over Latisse causing glaucoma. As you statred, Latisse contains Bimatoprost which is used to treat glaucoma but there is no risk of it causing this problem. The eye is exposed to a very small amount of Latisse even when it is properly applied as directed to the upper eyelid margin using the supplied applicator. This has been demonstrated by applying a colored dye to the eyelid margin and watching its migration. Fortunately, side effects from Latisse are quite uncommon. Over two million prescriptions for Latisse have now been filled with no confirmed reports of iris pigmentation issues. Less than 4 percent of people experienced redness, irritation and itching of the upper eyelid which was reversible upon discontinuation.
Glaucoma is a problem in which the pressure in the eye is too high and causes nerve damage. Lumigan (the same medicine as Latisse) is used to lower the pressure in the eye to prevent the damage from glaucoma. Lumigan will lower the pressure in the eye even if there is no glaucoma, but there have never been studies on using it for people who don't have eye pressure problems. There is no reason to believe that using Lumigan (or Latisse) will cause glaucoma. Latisse is even less likely to have any effect, because it is put on the eyelashes, not in the eye. Its effect on eye pressure is mild and not clinically significant.
Nearly all pharmacies, including CVS, carry Latisse. The cost runs between $100-150 with most places selling it at $120. It requires a prescription. However, I doubt most physicians that write prescriptions or sell it out of their offices require repeat office visits for a prescription unless...
Bimatoprost (marketed by Allergan under the name Latisse) is FDA approved for promoting eyelash growthPhase 2 clinical trials showed it did not help promote much scalp hair growth in men and women with genetic hair loss. The company plans to conduct a brand new study using a formulation that is...
Latisse has instructions to use one applicator per eyelid per night and it is packaged with 60 applicators so that is a month supply (except for those months with 31 days). Although it is not officially approved and "off label" many patients use one applicator and one drop for both...